Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Chinese Journal of Contemporary Pediatrics ; (12): 303-308, 2022.
Article in English | WPRIM | ID: wpr-928604


OBJECTIVES@#To study the association between paroxysmal nocturnal hemoglobinuria (PNH) clone and immunosuppressive therapy (IST) in children with severe aplastic anemia (SAA).@*METHODS@#A retrospective analysis was performed on the medical data of 151 children with SAA who were admitted and received IST from January 2012 to May 2020. According to the status of PNH clone, these children were divided into a negative PNH clone group (n=135) and a positive PNH clone group (n=16). Propensity score matching was used to balance the confounding factors, and the impact of PNH clone on the therapeutic effect of IST was analyzed.@*RESULTS@#The children with positive PNH clone accounted for 10.6% (16/151), and the median granulocyte clone size was 1.8%. The children with positive PNH clone had an older age and a higher reticulocyte count at diagnosis (P<0.05). After propensity score matching, there were no significant differences in baseline features between the negative PNH clone and positive PNH clone groups (P>0.05). The positive PNH clone group had a significantly lower overall response rate than the negative PNH clone group at 6, 12, and 24 months after IST (P<0.05). The evolution of PNH clone was heterogeneous after IST, and the children with PNH clone showed an increase in the 3-year cumulative incidence rate of aplastic anemia-PNH syndrome (P<0.05).@*CONCLUSIONS@#SAA children with positive PNH clone at diagnosis tend to have poor response to IST and are more likely to develop aplastic anemia-PNH syndrome.

Child , Humans , Anemia, Aplastic/drug therapy , Clone Cells , Hemoglobinuria, Paroxysmal/etiology , Immunosuppression Therapy , Retrospective Studies
Rev. pediatr. electrón ; 16(3): 21-27, oct. 2019. tab
Article in Spanish | LILACS | ID: biblio-1046282


La hemoglobinuria paroxística nocturna (HPN) es una enfermedad clonal y adquirida causada por una mutación somática en el gen PIG-A que se encuentra en el cromosoma X y codifica una proteína involucrada en la síntesis del glicosilfosfatidilinositol (GPI), el cual le sirve como anclaje a muchas proteínas de la membrana celular produciendo mayor sensibilidad al complemento. Los distintos signos y síntomas que se presentan tienen gran impacto en la calidad de vida de los pacientes, por lo que un diagnóstico correcto es de vital importancia. Actualmente, la citometría de flujo multiparamétrica es la metodología de elección para detectar y seguir al paciente con HPN.

Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal and acquired disease caused by a somatic mutation in the PIG-A gene found on the X chromosome and encoding a protein involved in the synthesis of glycosylphosphatidylinositol (GPI), which serves as anchoring to many proteins of the cell membrane producing greater sensitivity to complement. The different signs and symptoms that appear have a great impact on the quality of life of patients, so a correct diagnosis is of vital importance. Currently, multiparameter flow cytometry is the methodology of choice to detect and follow the patient with PNH.

Humans , Child , Hemoglobinuria, Paroxysmal/diagnosis , Hemoglobinuria, Paroxysmal/therapy , Diagnosis, Differential , Hemoglobinuria, Paroxysmal/classification , Hemoglobinuria, Paroxysmal/etiology
Archives of Iranian Medicine. 2011; 14 (6): 401-411
in English | IMEMR | ID: emr-137335


Arterial and venous thrombosis are interrelated disorders at the interplay of platelets and fibrin. Arterial thrombi are platelet-rich and occur at sites vulnerable to atherosclerotic plaque rupture where blood shear rates are high; on the contrary, venous thrombi occur in association with slow blood flow and shear rates. These differences may underlie why anti-platelet agents are more effective in prevention of arterial thrombosis, while anticoagulants are preferred for venous thrombosis. Although some common thrombophilic disorders [e.g., Factor V Leiden, prothrombin gene mutation, etc.] are almost exclusively associated with venous thromboembolism, there are several disorders that are important to consider when caring for patients with both arterial and venous thromboembolism. This article will review the evidence-based management of heparin induced thrombocytopenia with thrombosis, anti-phospholipid antibody syndrome and catastrophic anti-phospho-lipid antibody syndrome, thrombohemorrhagic manifestations of Philadelphia chromosome-negative chronic myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia and primary myelofibrosis, as well as paroxysmal nocturnal hemoglobinuria

Humans , Thrombocytopenia/drug therapy , Myeloproliferative Disorders/complications , Platelet Aggregation Inhibitors , Prognosis , Antiphospholipid Syndrome/drug therapy , Hemoglobinuria, Paroxysmal/etiology , Hemoglobinuria, Paroxysmal/therapy , Anticoagulants
Article in English | IMSEAR | ID: sea-87181


A young lady who had aplastic anaemia presented for cerebral venous thrombosis after five years of follow up. She was diagnosed to have paroxysmal nocturnal haemoglobinuria. She had received immunosuppressive therapy with methylprednisolone, cyclosporine-A, anti-lymphocyte globulin, danazol and pregnenolone. The relation between aplastic anaemia, paroxysmal nocturnal haemoglobinuria and cerebral venous thrombosis is discussed. The role of immunosuppressive therapy for aplastic anaemia in causation of paroxysmal nocturnal haemoglobinuria is reviewed.

Adult , Anemia, Aplastic/chemically induced , Female , Hemoglobinuria, Paroxysmal/etiology , Humans , Immunosuppressive Agents/adverse effects , Magnetic Resonance Imaging , Sagittal Sinus Thrombosis/diagnosis
Rev. HCPA & Fac. Med. Univ. Fed. Rio Gd. do Sul ; 9(3): 188-94, dez. 1989. ilus, tab
Article in Portuguese | LILACS | ID: lil-112974


hemoglobinúria Paroxistica Noturna (HPN) é uma doença hemolítica crônica adquirida. Depende de uma mutaçäo somática que ocorre na célula progenitora hemopoética (Stem cell). Essa anormalidade expressa-se por uma interaçäo anômala de membrana celular com os componentes do complemento plasmática provocando a disfunçäo ou destruiçäo celular. Aspectos novos da fisiopatogenia säo apresentados. manifesta-se, na maioria dos pacientes, por hemólise intravascular crônica sem um padräo noturmo clássico, por pancitopenia, deficiencia de ferro, ou episódios trombóticos recorrentes. O diagnóstico é baseado numa série de testes que avaliam a sensibilidade à lise por fraçöes do sistema do complemento. Tratamento consiste basicamente em medidas de suporte como transfusöes sangüíneas e anticoagulantes. Atualmente duas novas técnicas como transplante de medula e terapêutica fibrinolítica têm melhorado o prognóstico

Humans , Male , Female , Anemia, Hemolytic, Autoimmune , Hemoglobinuria, Paroxysmal/therapy , Diagnosis, Differential , Hemoglobinuria, Paroxysmal/etiology
Indian Pediatr ; 1977 Mar; 14(3): 219-21
Article in English | IMSEAR | ID: sea-14911